Back
 ABCR  Vol.5 No.3 , July 2016
Concomitant Boost Radiotherapy after Conservative Breast Surgery in Early Breast Cancer
Abstract: Background: Radiation therapy after breast conserving surgery is a standard part of treatment for invasive breast cancer. Based on radiobiological models, it was found that shorter radiation schedules offered the promise of equivalent local control to standard radiation therapy by giving larger doses per fraction in shorter period of time. Methods: This study included 36 female patients with operable invasive stage I-II breast cancer. These patients underwent microscopic wide local excision of the primary tumor and lymph node dissection. They received adjuvant radiotherapy. The radiation dose was 40 Gy total dose in 15 fractions for whole breast and additional dose of 9 Gy in three consecutive fractions was delivered to tumour cavity simultaneously. Results: Mean age was 52 years (range: 30 - 67); most patients were of stage II disease and Grade II was the most common one. Invasive ductal carcinoma was reported in 94.4% and 72.2% of patients were hormone receptor positive. After median follow-up of 52 months, all patients were alive and ipsilateral local recurrence was reported in 1 case only. Grade IV radiation toxicity was not observed; moist desquamation was the most common acute reaction (61%) with grade III in 5.5% followed by dry desquamation in 55.6% of grade I only. Grade I erythema was recorded in 41.7% and grade II in 11%. Fibrosis was the most frequent late reaction (44.3%) with grade II in 11% followed by telengectesia then pigmentation (41.7%, 33.3% respectively). Conclusion: The regimen used in this study appears promising with acceptable acute toxicities and convenient for our patients and has the advantage of economic use of radiation facilities. However, larger number of patients and longer period of follow-up are needed for further evaluation.
Cite this paper: El-Hadaad, H. , Wahba, H. , Elnahas, W. and Roshdy, S. (2016) Concomitant Boost Radiotherapy after Conservative Breast Surgery in Early Breast Cancer. Advances in Breast Cancer Research, 5, 97-102. doi: 10.4236/abcr.2016.53011.
References

[1]   (2010) Landlijke werkgroep behandeling van het mammacarcinoom. Accessed 4 September.
http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&id=27539&richtlijn_id=593

[2]   Clarke, M., Collins, R., Darby, S., et al. (2005) Effects of Radiotherapy and of Differences in the Extent of Surgery for Early Breast Cancer on Local Recurrence and 15-Year Survival: An Overview of the Randomized Trials. The Lancet, 366, 2087-2106.
http://dx.doi.org/10.1016/S0140-6736(05)67887-7

[3]   Fisher, B., Anderson, S., Bryant, J., et al. (2002) Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer. The New England Journal of Medicine, 347, 1233-1241.
http://dx.doi.org/10.1056/NEJMoa022152

[4]   van der Laan, H.P., Hurkmans, C.W., Kuten, A., et al. (2010) Current Technological Clinical Practice in Breast Radiotherapy; Results of a Survey in EORTC-Radiation Oncology Group Affiliated Institutions. Radiotherapy & Oncology, 94, 280-285.
http://dx.doi.org/10.1016/j.radonc.2009.12.032

[5]   Ballard-Barbash, R., Potosky, A.L., Harlan, L.C., et al. (1996) Factors Associated with Surgical and Radiation Therapy for Early Breast Cancer in Older Women. Journal of the National Cancer Institute, 88, 716-726.
http://dx.doi.org/10.1093/jnci/88.11.716

[6]   Zubizarreta, E.H., Poitevin, A. and Levin, C.V. (2004) Overview of Radiotherapy Resourses in Latin America: A Survey by the International Atomic Energy Agency (IAEA). Radiotherapy & Oncology, 73, 97-100.
http://dx.doi.org/10.1016/j.radonc.2004.07.022

[7]   Barton, M.B., Frommer, M. and Shafiq, J. (2006) Role of Radiotherapy in Cancer Control in Low-Income and Middle-Income Countries. The Lancet Oncology, 7, 584-595.
http://dx.doi.org/10.1016/S1470-2045(06)70759-8

[8]   Bentzen, S.M., Agrawal, R.K., Aird, E.G., et al., START Trialists Group (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: A Randomized trial. The Lancet Oncology, 9, 331-341.
http://dx.doi.org/10.1016/S1470-2045(08)70077-9

[9]   Bentzen, S.M., Agrawal, R.K., Aird, E.G., et al., START Trialists Group (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: A Randomized trial. The Lancet Oncology, 371, 1098-1107.
http://dx.doi.org/10.1016/S0140-6736(08)60348-7

[10]   Whelan, T., Pigno, J., Levine, M., et al. (2010) Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. The New England Journal of Medicine, 362, 513-520.
http://dx.doi.org/10.1056/NEJMoa0906260

[11]   Guerrero, M., Li, X.A., Earl, M.A., et al. (2004) Simultaneous Integrated Boost for Breast Cancer Using IMRT: A Radiobiological and Treatment Planning Study. International Journal of Radiation Oncology * Biology * Physics, 59, 1513-1522.
http://dx.doi.org/10.1016/j.ijrobp.2004.04.007

[12]   Van der Laan, H.P., Dolsma, W.V., Maduro, J.H., et al. (2007) Three-Dimensional Conformal Simultaneously Integrated Boost Technique for Breast-Conserving Radiotherapy. International Journal of Radiation Oncology * Biology * Physics, 68, 1018-1023.
http://dx.doi.org/10.1016/j.ijrobp.2007.01.037

[13]   (2005) Primary Therapy of Early Breast Cancer. 9th International Conference on Breast, Volume 14, St Gallen, Switzerland, 26-29 January 2005, S1-S56.
http://www.ncbi.nlm.nih.gov/pubmed/15776545

[14]   Cox, J.D., Stetz, J. and Pajak, T.F. (1995) Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology * Biology * Physics, 31, 1041-1042.
http://dx.doi.org/10.1016/0360-3016(95)00060-C

[15]   Fowler, J.F. (1989) The Linear-Quadratic Formula and Progress in Fractionated Radiotherapy. The British Journal of Radiology, 62, 679-694.
http://dx.doi.org/10.1259/0007-1285-62-740-679

[16]   Jalali, R., Malde, R., Bhutani, R., et al. (2008) Prospective Evaluation of Concomitant Tumor Bed Boost with Whole Breast Irradiation in Patients with Locally Advanced Breast Cancer Undergoing Breast-Conserving Therapy. Breast, 17, 64-70.
http://dx.doi.org/10.1016/j.breast.2007.07.033

[17]   Corvo, R., Giudici, S., Maggio, F., et al. (2008) Weekly Concomitant Boost in Adjuvant Radiotherapy for Patients with Early Breast Cancer: Preliminary Results on Feasibility. Tumori, 94, 706-711.

[18]   Fujii, O., Hiratsuka, J., Nagase, N., et al. (2008) Whole Breast Radiotherapy with Shorter Fractionation Schedules Following Breast-Conserving Surgery: Short-Term Morbidity and Preliminary Outcomes. Breast Cancer, 15, 86-92.
http://dx.doi.org/10.1007/s12282-007-0010-3

[19]   Olivotto, I.A., Weir, L.M., Kim-Sing, C., et al. (1996) Late Cosmetic Results of Short Fractionation for Breast Conservation. Radiotherapy & Oncology, 41, 7-13.
http://dx.doi.org/10.1016/S0167-8140(96)91824-1

[20]   Shelly, W., Brundage, M., Hayter, C., et al. (2000) A Shorter Fractionation Schedule for Post Lumpectomy Breast Cancer Patients. International Journal of Radiation Oncology * Biology * Physics, 47, 1219-1228.
http://dx.doi.org/10.1016/S0360-3016(00)00567-8

[21]   Guenzi, M., Vagge, S., Azinwi, N.C., et al. (2010) A Biologically Competitive 21 Days Hypofractionation Scheme with Weekly Concomitant Boost in Breast Cancer Radiotherapy Feasibility Acute Sub-Acute and Short Term Late Effects. Radiotherapy & Oncology, 5, 111.
http://dx.doi.org/10.1186/1748-717X-5-111

[22]   Ciammella, P., Podgornii, A., Galeandro, M., et al. (2014) Toxicity and Cosmetic Outcome of Hypofractionated Whole-Breast Radiotherapy: Predictive Clinical and Dosimetric Factors. Radiotherapy & Oncology, 9, 97.
http://dx.doi.org/10.1186/1748-717X-9-97

[23]   Scorsetti, M., Alongi, F., Fogliata, A., et al. (2012) Phase I-II Study of Hypofractionated Simultaneous Integrated Boost Using Volumetric Modulated Arc Therapy for Adjuvant Radiation Therapy in Breast Cancer Patients: A Report of Feasibility and Early Toxicity Results in the First 50 Treatments. Radiotherapy & Oncology, 28, 145.

 
 
Top